Status:
COMPLETED
Human Factors Validation Testing for the Peripal System; a Manual Connection Assist Device for Peritoneal Dialysis Devices
Lead Sponsor:
Peripal AG
Collaborating Sponsors:
Swiss Federal Institute of Technology
University Hospital Birmingham NHS Foundation Trust
Conditions:
End Stage Renal Failure on Dialysis
End Stage Renal Disease on Dialysis
Eligibility:
All Genders
Phase:
NA
Brief Summary
It is estimated that there are currently over 3 million patients receiving dialysis treatment worldwide. With effective pre-dialysis counselling, a majority of patients choose the home-based therapy p...
Detailed Description
The growth in the renal replacement therapy population is primaryly in the elderly age group, a population with a high frailty and comorbidity burden. Facilitating PD in this group of patients require...
Eligibility Criteria
Inclusion
- Fifteen patients and nine carers volunteered in this study, ranging from 23 to 86 years in age and from 0.3 to 24 years in experience in the PD therapy.
Exclusion
Key Trial Info
Start Date :
February 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2018
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04292210
Start Date
February 19 2018
End Date
April 30 2018
Last Update
March 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NIHR Trauma Management MedTech Co-operative
Birmingham, United Kingdom